No effect of omega-3 fatty acid supplementation on cognition and mood in individuals with cognitive impairment and probable Alzheimer’s disease: A randomised controlled trial

International Journal of Molecular Sciences

Volumn 16, Issue 10, 2015, Pages 24600-24613

  Phillips, Michelle A ^a   Childs, Caroline E ^b   Calder, Philip C ^b,c   Rogers, Peter J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Alzheimer s disease (AD); Cognitive impairment no dementia (CIND); Docosahexaenoic acid (DHA); Eicosapentaenoic acid (EPA); Omega 3 fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; PLACEBO;

AGED; ALZHEIMER DISEASE; ARTICLE; BRISTOL ACTIVITIES OF DAILY LIVING SCALE; CLOCK DRAWING TEST; COGNITIVE DEFECT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY COMPLIANCE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MINI MENTAL STATE EXAMINATION WORLD BACKWARD; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; AFFECT; DIETARY SUPPLEMENT; DRUG EFFECTS; PATHOPHYSIOLOGY;

AFFECT; AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE;

EID: 84945232266     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161024600     Document Type: Article

References (42)

1. Lunn, J.; Theobald, H.E. The health effects of dietary unsaturated fatty acids. Nutr. Bull. 2006, 31, 178-224.
2. Iso, H.; Rexrode, K.M.; Stampfer, M.J.; Manson, J.E.; Colditz, G.A.; Speizer, F.E.; Hennekens, C.H.; Willett, W.C. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001, 285, 304-312.
3. Virtanen, J.K.; Siscovick, D.S.; Longstreth, W.T.; Kuller, L.H.; Mozaffarian, D. Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology 2008, 71, 439-446.
4. Hornstra, G. Influence of dietary fat type on arterial thrombosis tendency. J. Nutr. Health Aging 2001, 5, 160-166.
5. Von Schacky, C.; Harris, W.S. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc. Res. 2007, 73, 310-315.
6. Sydenham, E.; Dangour, A.D.; Lim, W.S. Omega-3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst. Rev. 2012, 13, 419.
7. Vakhapova, V.; Cohen, T.; Richter, Y.; Herzog, Y.; Korczyn, A.D. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: A double-blind placebo-controlled trial. Dement. Geriatr. Cogn. Disord. 2010, 29, 467-474.
8. Otsuka, M. Analysis of dietary factors in Alzheimer's disease: Clinical use of nutritional intervention for prevention and treatment of dementia. Nippon Ronen Igakkai Zasshi 2000, 37, 970-973.
9. Yehuda, S.; Rabinovtz, S.; Carasso, R.L.; Mostofsky, D.I. Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. Int. J. Neurosci. 1996, 87, 141-149.
10. Boston, P.F.; Bennett, A.; Horrobin, D.F.; Bennett, C.N. Ethyl-EPA in Alzheimer's disease—A pilot study. Prostaglandins Leukot. Essent. Fatty Acids 2004, 71, 341-346.
11. Freund-Levi, Y.; Eriksdotter-Jonhagen, M.; Cederholm, T.; Basun, H.; Faxen-Irving, G.; Garlind, A.; Vedin, I.; Vessby, B.; Wahlund, L.-O.; Palmblad, J. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: A randomized double-blind trial. Arch. Neurol. 2006, 63, 1402-1408.
12. Freund-Levi, Y.; Basun, H.; Cederholm, T.; Faxen-Irving, G.; Garlind, A.; Grut, M.; Vedin, I.; Palmblad, J.; Wahlund, L.-O.; Eriksdotter-Jonhagen, M. Omega-3 supplementation in mild to moderate Alzheimer's disease: Effects on neuropsychiatric symptoms. Int. J. Geriatr. Psychiatry 2008, 23, 161-169.
13. Appleton, K.M.; Hayward, R.C.; Gunnell, D.; Peters, T.J.; Rogers, P.J.; Kessler, D.; Ness, A.R. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: Systematic review of published trials. Am. J. Clin. Nutr. 2006, 84, 1308-1316.
14. Kontani, S.; Sakaguchi, E.; Warashina, S.; Matsukawa, N.; Ishikura, Y.; Kiso, Y.; Sakakibara, M.; Yoshimoto, T.; Guo, J.; Yamashima, T. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci. Res. 2006, 56, 159-164.
15. Chiu, C.C.; Su, K.P.; Cheng, T.C.; Lui, H.C.; Chang, C.J.; Dewey, M.E.; Stewart, R.; Huang, S.Y. The effects of Omega-3 fatty acids monotherapy in Alzheimer's Disease and Mild Cognitive Impairment: A preliminary randomized double blind placebo controlled study. Prog. Neuro-Psychopharmacol. 2008, 32, 1538-1544.
16. Dangour, A.D.; Allen, E.; Elbourne, D.; Fasey, N.; Fletcher, A.E.; Hardy, P.; Holder, G.E.; Knight, R.; Letley, L.; Richards, M et al. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: A randomized, double-blind, controlled trial. Am. J. Clin. Nutr. 2010, 91, 1725-1732.
17. Van de Rest, O.; Geleijnse, J.M.; Kok, F.J.; van Staveren, W.A.; Hoefnagels, W.H.; Beekman, A.T.F.; de Groot, L.C.P.G.M. Effects of fish-oil supplementation on mental well-being in older subjects: A randomised, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 2008, 88, 706-713.
18. Van de Rest, O.; Geleijnse, J.M.; Kok, F.J.; van Staveren, W.A.; Dullemeijer, C.; OldeRikkert, M.G.M.; Beekman, A.T.F.; de Groot, C.P.G.M. Effect of fish oil on cognitive performance in older subjects. Neurology 2008, 71, 430-438.
19. Geleijnse, J.M.; Giltay, E.J.; Kromhout, D. Effects of n-3 fatty acids on cognitive decline: A randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients. Alzheimers Dement. 2012, 8, 278-287.
20. Nelson, H.E.; Willison, J.R. National Adult Reading Test (NART). Test Manual Including New Data Supplement; NFER-NELSON: Windsor, ON, Canada, 1991.
21. Terano, T.; Fujishiro, S.; Ban, T.; Yamamoto, K.; Tanaka, T.; Noguchi, Y.; Tamura, Y.; Yazawa, K.; Hirayama, T. Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids 1999, 34, S345-S346.
22. Grosso, G.; Pajak, A.; Marventano, S.; Castellano, S.; Bucolo, C.; Drago, F.; Caraci, F. Role of omega-3 fatty acids in the treatment of depressive disorders: A comprehensive meta-analysis of randomized clinical trials. PLoS ONE 2014, 9, e96905.
23. Browning, L.M.; Walker, C.G.; Mander, A.P.; West, A.L.; Madden, J.; Gambell, J.M.; Young, S.; Wang, L.; Jebb, S.A.; Calder, P.C. Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am. J. Clin. Nutr. 2012, 96, 748-758.
24. Bascoul, C. How can omega-3 fatty acids prevent Alzheimer's disease? Cardiff University, Cardiff, UK. Unpublished conference poster, 2007.
25. Newman, P.E. Alzheimer's disease revisited. Med. Hypotheses 2000, 54, 774-776.
26. In 't Veld, B.A.; Ruitenberg, A.; Hofman, A.; Launer, L.J.; van Duijn, C.K.; Stinjen T.; Breteler, M.B.B.; Stricker, B.H.C. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 2001, 345, 1515-1521.
27. Phillips, M.; Childs, C.; Calder, P.; Rogers, P. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparision of individuals with and without cognitive impairment and Alzheimer's disease. Nutr. Neurosci. 2012, 15, 271-277.
28. Simopoulos, A.P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother. 2002, 56, 365-379.
29. Simopoulos, A.P. Omega-3 Fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 2002, 21, 495-505.
30. Pedrosa, H.; de Sa, A.; Guerreiro, M.; Maroco, J.; Simoes, M.R.; Galasko, D.; de Mendonca, A. Functional evaluation distinguishes MCI patients from healthy elderly people—The ADCS/MCI/ADL scale. J. Nutr. Health Aging 2010, 14, 703-709.
31. McKhann, G.; Drachman, D.; Folstein, M.; Katzman, R.; Price, D.; Stadlan, E.M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group* under the auspoces of department of health and human services task force on Alzheimer's disease. Neurology 1984, 34, 939-944.
32. Levy, R. Aging associated cognitive decline. Int. Psychogeriatr. 1994, 6, 63-68.
33. Petersen, R.C. Mild cognitive impairment as a diagnostic entity. Intern. Med. 2004, 256, 183-194.
34. Fisk, H.L.; West, A.L.; Childs, C.E.; Burdge, G.C.; Calder, P.C. The use of gas chromatography to analyze compositional changes of fatty acids in rat liver tissue during pregnancy. J. Vis. Exp. 2014, doi:10.3791/51445.
35. Folstein, M.F.; Folstein, S.E.; McHugh, P.R. "Mini-mental State": A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12, 189-198.
36. Brandt, J. The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms. Clin. Neuropsychol. 1991, 5, 125-142.
37. Adshead, F.; Cody, D.D.; Pitt, B. BASDEC: A novel screening instrument for depression in elderly medical in-patients. Br. Med. J. 1992, 305, 397.
38. Royall, D.R.; Cordes, J.A.; Polk, M. CLOX: An executive clock drawing task. J. Neurol. Neurosur. Psychiatry 1998, 64, 588-594.
39. Kaplan, E.; Goodglass, H.; Weintraub, S. Boston Naming Test, 2nd ed.; Lippincott Williams and Wilkins: Baltimore, MD, USA, 2001.
40. Wechsler, A. Wechsler Adult Intelligence Scale, 3rd ed.; Pearson Publisher: Oxford, UK, 1999.
41. Wilson, B.A.; Clare, L.; Baddeley, A.; Cockburn, J.; Watson, P.; Tate, R. The Rivermead Behavioural Memory Test—Extended Version; Thames valley Test Company: Bury St. Edmonds, UK, 1998.
42. Bucks, R.S.; Ashworth, D.L.; Wilcock, G.K.; Siegfried, K. Assessment of activities of daily living in dementia: Development of the Bristol activities of daily living scale. Age Ageing 1996, 25, 113-120.